MCID: GRV012
MIFTS: 38

Grover's Disease malady

Categories: Rare diseases, Skin diseases

Aliases & Classifications for Grover's Disease

About this section

Aliases & Descriptions for Grover's Disease:

Name: Grover's Disease 48 68
Persistent Acantholytic Dermatosis 48
Transient Acantholytic Dermatosis 48
 
Grover Disease 48
Tad 48

Classifications:



External Ids:

ICD1030 L11.1

Summaries for Grover's Disease

About this section
NIH Rare Diseases:48 Grover's disease is a skin condition that causes the appearance of small, red spots. These spots usually develop on the chest or back, but may also form on other parts of the body. This condition frequently leads to intense itching, although it may cause no symptoms. Most cases last six to twelve months. Occasionally, this condition may persist for longer periods, or it may come and go over time. The exact cause is unknown; however, a number of factors may cause or worsen the condition including heat and sweating. While there is no cure for Grover's disease, there may be ways to manage the condition, such as avoidance of factors that worsen symptoms, moisturizers, and topical corticosteroids. Last updated: 12/21/2016

MalaCards based summary: Grover's Disease, also known as persistent acantholytic dermatosis, is related to pemphigus and lymphoma, and has symptoms including dry skin, warm skin and burning sensation of skin. An important gene associated with Grover's Disease is DSP (Desmoplakin), and among its related pathways are Cell adhesion_Endothelial cell contacts by junctional mechanisms and Antiarrhythmic Pathway, Pharmacodynamics. Affiliated tissues include skin, bone marrow and heart.

Wikipedia:71 Grover\'s disease (GD), also known as benign papular acantholytic dermatosis,transient acantholytic... more...

Related Diseases for Grover's Disease

About this section

Graphical network of the top 20 diseases related to Grover's Disease:



Diseases related to grover's disease

Symptoms & Phenotypes for Grover's Disease

About this section

UMLS symptoms related to Grover's Disease:


dry skin, warm skin, burning sensation of skin, pain of skin, macule, peau d'orange surface of breast, macerated skin (finding), yellow complexion, skin discomfort, painful scar, application site papules, eyelid margin crusting, eyelid pain, injection site dryness, eyelid skin dryness, pathergy reaction

Drugs & Therapeutics for Grover's Disease

About this section

Drugs for Grover's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 39)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MetforminapprovedPhase 3, Phase 21746657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
2
Balsalazideapproved, investigationalPhase 3780573-04-26335412
Synonyms:
(3Z)-3-[[4-(2-carboxyethylcarbamoyl)phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid
(E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid
(E)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid
(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid
(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid
3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid
5-[(E)-{4-[(2-carboxyethyl)carbamoyl]phenyl}diazenyl]-2-hydroxybenzoic acid
5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid
5-[4-(2-carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid
80573-04-2
AC1O3RJF
Ambap80573-04-2
BALSALAZIDE
BIDD:GT0772
Balsalazida
Balsalazida [Spanish]
Balsalazide (INN)
Balsalazide Disodium
 
Balsalazide [INN:BAN]
Balsalazide disodium
Balsalazido
Balsalazido [Spanish]
Balsalazidum
Balsalazidum [Latin]
C17H15N3O6
CHEBI:267413
CID6335412
CPD000469221
Colazal
D07488
DB01014
HMS2052K19
LS-36369
MLS001424257
SAM001246804
SMR000469221
UNII-P80AL8J7ZP
3
Guaifenesinapproved, vet_approvedPhase 361693-14-13516
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
Amonidren
Amonidrin
Aresol
Benylin-E
Bronchol
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
 
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphesin
Hustosil
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
Pneumomist
Propanosedyl
Reduton
Robitussin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
guaiphenesin
p-Cresyl acetate
4
Magnesium oxideapprovedPhase 3, Phase 2631309-48-414792
Synonyms:
 
Magmitt
5
Propranololapproved, investigationalPhase 3216525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
6
Inulinapproved, nutraceuticalPhase 31029005-80-524763
Synonyms:
(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethy
189444-25-5
887747-94-6
AC1L2NNM
AI3-19506
CID24763
DB00638
 
EINECS 232-684-3
INULIN
Inulin USP 27
Inulin [BAN]
Inulin and sodium chloride
Inulin from Jerusalem artichokes
LS-186416
LS-187349
7Peripheral Nervous System AgentsPhase 322776
8Vasodilator AgentsPhase 33438
9MesalaminePhase 316089-57-6
10AntacidsPhase 3, Phase 21767
11Adrenergic beta-AntagonistsPhase 31154
12Anti-Arrhythmia AgentsPhase 32969
13Neurotransmitter AgentsPhase 317734
14Antihypertensive AgentsPhase 34095
15Adrenergic AntagonistsPhase 31535
16Adrenergic AgentsPhase 35140
17insulinPhase 34524
18Hypoglycemic AgentsPhase 3, Phase 25733
19Gastrointestinal AgentsPhase 3, Phase 28109
20Anti-Ulcer AgentsPhase 3, Phase 21767
21Insulin, Globin ZincPhase 34523
22AnalgesicsPhase 311287
23Antirheumatic AgentsPhase 310627
24Anti-Inflammatory Agents, Non-SteroidalPhase 34295
25Anti-Inflammatory AgentsPhase 310355
26Analgesics, Non-NarcoticPhase 36260
27Chlorpheniramine, phenylpropanolamine drug combinationPhase 3616
28MitomycinsPhase 2, Phase 3233
29
GlyburideapprovedPhase 211110238-21-83488
Synonyms:
1-((P-(2-(5-chloro-O-Anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea
1-(P-(2-(5-chloro-2-Methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea
10238-21-8
5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide
5-chloro-N-(2-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide
5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
AB00051949
AC1L1G1Q
AC1Q44V7
AKOS001487495
Abbenclamide
Adiab
Apo-Glibenclamide
Azuglucon
BIDD:GT0239
BPBio1_000344
BRD-K36927236-001-06-0
BRN 2230085
BSPBio_000312
BSPBio_001351
BSPBio_003053
Bastiverit
Benclamin
Betanase
Betanese 5
Bio-0156
Bio1_000076
Bio1_000565
Bio1_001054
Bio2_000071
Bio2_000551
C07022
C23H28ClN3O5S
CAS-10238-21-8
CBiol_001790
CHEBI:5441
CHEMBL472
CID3488
CPD000058229
Calabren
Cytagon
D00336
D005905
DB01016
Daonil
Debtan
Dia-basan
Diabeta
Diabeta (TN)
Diabiphage
Dibelet
DivK1c_000481
Duraglucon
EINECS 233-570-6
EU-0100499
Euclamin
Euglucan
Euglucon
Euglucon 5
Euglucon N
Euglykon
G 0639
G0639_SIAL
G0639_SIGMA
G2539_SIAL
GBN 5
Gen-Glybe
Gewaglucon
Gilemal
Glamide
Glibadone
Gliban
Gliben
Gliben-Puren N
Glibenbeta
Glibenclamid AL
Glibenclamid Basics
Glibenclamid Fabra
Glibenclamid Genericon
Glibenclamid Heumann
Glibenclamid Riker M
Glibenclamid Riker M.
Glibenclamid-Cophar
Glibenclamid-Ratiopharm
Glibenclamida
Glibenclamida [INN-Spanish]
Glibenclamide
Glibenclamide (JP15/INN)
Glibenclamidum
Glibenclamidum [INN-Latin]
Glibenil
Glibens
Glibesyn
Glibet
Glibetic
Glibil
Gliboral
Glicem
Glidiabet
Glimel
Glimide
Glimidstata
Glisulin
Glitisol
Glubate
Gluben
Gluco-Tablimen
Glucobene
Glucohexal
Glucolon
Glucomid
Glucoremed
Glucoven
Glyben
Glybenclamide
Glybenzcyclamide
Glyburide
Glyburide (USP)
Glyburide (micronized)
Glyburide [USAN]
 
Glycolande
Glycomin
Glynase
Glynase (TN)
HB 419
HB 420
HB-419
HB-420
HB419
HB420
HMS1361D13
HMS1568P14
HMS1791D13
HMS1922L08
HMS1989D13
HMS2089L06
HMS2093P04
HMS501I03
Hemi-Daonil
Hexaglucon
Humedia
I06-0716
IDI1_000481
IDI1_033821
KBio1_000481
KBio2_000071
KBio2_000730
KBio2_002639
KBio2_003298
KBio2_005207
KBio2_005866
KBio3_000141
KBio3_000142
KBio3_002273
KBioGR_000071
KBioGR_001897
KBioSS_000071
KBioSS_000730
LS-159295
Lederglib
Libanil
Lisaglucon
Lopac-G-0639
Lopac0_000499
MLS000069721
MLS001077262
Malix
Maninil
Med-Glionil
Melix
Micronase
Micronase (TN)
Micronized glyburide
Miglucan
MolPort-000-784-850
N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)-ethyl]benzene-sulfonyl-N -cyclohexylurea
N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea
NCGC00015467-01
NCGC00015467-02
NCGC00015467-06
NCGC00015467-16
NCGC00016689-01
NCGC00023447-02
NCGC00023447-04
NCGC00023447-05
NCGC00023447-06
NCGC00023447-07
NCGC00023447-08
NCGC00023447-09
NCGC00023447-10
NCGC00023447-11
NCGC00023447-12
NINDS_000481
Nadib
Neogluconin
Norglicem 5
Normoglucon
Novo-Glyburide
Oprea1_764617
Orabetic
Pira
Praeciglucon
PresTab
Prestwick0_000316
Prestwick1_000316
Prestwick2_000316
Prestwick3_000316
Prestwick_569
Probes1_000431
Probes2_000378
Prodiabet
Renabetic
S1716_Selleck
SAM002564212
SMR000058229
SPBio_001831
SPBio_002531
SPECTRUM2300229
SR-01000000196-5
STK362992
Semi-Daonil
Semi-Euglucon
Semi-Gliben-Puren N
Semi-daonil
Spectrum2_001816
Spectrum3_001327
Spectrum4_001199
Spectrum5_001631
Spectrum_000250
Sugril
Suraben
Tiabet
Tocris-0911
U 26452
U-26452
UNII-SX6K58TVWC
UPCMLD-DP006
UPCMLD-DP006:001
UR 606
Yuglucon
ZINC00537805
glibenclamide
glyburide
30FlaxNutraceuticalPhase 295
31TeaNutraceuticalPhase 2317
32LinoleateNutraceuticalPhase 271
33leucineNutraceuticalPhase 2110
34
Mannitolapproved, investigational26869-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
35
Lactuloseapproved944618-18-211333
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-O-b-D-Galactopyranosyl-D-Fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-D-Galactopyranosyl-D-Fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-Fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
 
Bifiteral
Cephulac
D-Lactulose
Lactulosa
Lactulose
Lactulosum
delta-Lactulose
lactulosa
lactulosum
36Natriuretic Agents1645
37diuretics1372
38Alkylating Agents4694
39ColaNutraceutical1881

Interventional clinical trials:

(show all 25)
idNameStatusNCT IDPhase
1Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary BypassCompletedNCT00032630Phase 3
2Combination of Metformin/Inulin vs Inulin on Adiponectin in Metabolic SyndromeCompletedNCT02773927Phase 3
3Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic SyndromeCompletedNCT02778776Phase 3
4Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative ColitisCompletedNCT00408174Phase 3
5Beta-Blocker Heart Attack Trial (BHAT)CompletedNCT00000492Phase 3
6InnFocus MicroShunt Versus Trabeculectomy StudyRecruitingNCT01881425Phase 2, Phase 3
7Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic SyndromeNot yet recruitingNCT02629627Phase 2
8Effect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes MellitusNot yet recruitingNCT02627898Phase 2
9Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina PectorisSuspendedNCT01567592Phase 1
10A Multidisciplinary e-Health Program to Promote Regular Physical ActivityCompletedNCT02035254
11The Healthy Options Feasibility StudyCompletedNCT00746460
12Alice PDx User/Validation Extended TrialCompletedNCT00841906
13A Randomized Control Trial of a Simulation-based Curriculum to Enhance Skills in ColonoscopyCompletedNCT01991522
14Traumatic Brain Injury in Veterans and Near-Infrared PhototherapyCompletedNCT02635516
15Tissue Sample Collection From Patients With Fanconi AnemiaCompletedNCT00899522
16Biomarkers for Intestinal Permeability in Patients With ConstipationRecruitingNCT02246647
17Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to HealtRecruitingNCT03010826
18A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)RecruitingNCT02477319
19Colonoscopic Skill Acquisition and Transfer Via Simulated Curriculum of Progressive TrainingRecruitingNCT02000180
20Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes (ETT).RecruitingNCT02181894
21Cataract Removal and Alzheimer's DiseaseActive, not recruitingNCT00921297
22Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or MyelomaActive, not recruitingNCT00900055
23the Canadian Health Improvement Network to Upgrade Prevention ServicesEnrolling by invitationNCT02310685
24Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy ParticipantsTerminatedNCT00896740
25Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy VolunteersTerminatedNCT00899795

Search NIH Clinical Center for Grover's Disease

Genetic Tests for Grover's Disease

About this section

Anatomical Context for Grover's Disease

About this section

MalaCards organs/tissues related to Grover's Disease:

36
Skin, Bone marrow, Heart, Bone, Myeloid, Brain, Prostate

Publications for Grover's Disease

About this section

Articles related to Grover's Disease:

(show all 37)
idTitleAuthorsYear
1
Transient acantholytic dyskeratosis (Grover's disease) after bone marrow transplantation. (27358215)
2016
2
Dermoscopy of Grover's disease: Variability according to histological subtype. (26892381)
2016
3
A case report of Grover's disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1. (27660709)
2016
4
Grover's disease in chronic kidney failure. (26299177)
2015
5
Pruritic Papules Following Lumbar Corset Use: A Quiz. Grover's disease. (25708298)
2015
6
Grover's disease and cutaneous melanoma: a fortuitous association or a paraneoplastic case? (26159656)
2015
7
Grover's Disease in a Liver Transplant Patient. (24648700)
2014
8
Grover's Disease with Acrosyringeal Acantholysis: A Rare Histological Presentation of an Uncommon Disease. (25484405)
2014
9
Transient acantholytic dermatosis (Grover's disease) with an isolated eruption. (23783409)
2013
10
Is Grover's disease an autoimmune dermatosis? (24131368)
2013
11
Grover's disease in a peritoneal dialysis patient. (23897199)
2013
12
Grover's disease secondarily infected with herpes simplex virus and Staphylococcus aureus: case report and review. (23013197)
2013
13
Dermatoscopy of Grover's disease and solitary acantholytic dyskeratoma shows a brown, star-like pattern. (23157785)
2012
14
Grover's disease in a renal transplant patient, after hemodialysis renewal. (22481593)
2012
15
Grover's disease following multiple bilateral Blaschko lines: a rare clinical presentation with genetic and electron microscopic analyses. (23075809)
2012
16
Grover's Disease after Heart Transplantation: A Case Report. (23320241)
2012
17
Leukemia cutis in association With Grover's disease. (21242761)
2011
18
Grover's disease associated with pregnancy. (20507412)
2010
19
Grover's disease and mercury. (19827971)
2010
20
Paraneoplastic transient acantholytic dermatosis (Grover's disease) along Blaschko lines. (19467976)
2009
21
Grover's disease induced by cetuximab. (16778425)
2006
22
Transient acantholytic dermatosis (Grover's disease) in a renal transplant patient. (16620222)
2006
23
A case of Grover's disease with syringoma-like features and leukemia cutis. (16776721)
2006
24
Grover's disease (transient acantholytic dermatosis) associated with atopy. (15857481)
2005
25
Medium-dose ultraviolet A1 phototherapy in transient acantholytic dermatosis (Grover's disease). (15627107)
2005
26
Unilateral transient acantholytic dermatosis (Grover's disease) along Blaschko lines. (12140485)
2002
27
Grover's disease, despite histological similarity to Darier's disease, does not share an abnormality in the ATP2A2 gene. (10971355)
2000
28
Incidence of transient acantholytic dermatosis (Grover's disease) in a hospital setting. (10490299)
1999
29
Grover's disease (transient acantholytic dermatosis): relationship of acantholysis to acrosyringia. (9870673)
1998
30
Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine. (9248901)
1997
31
Transient acantholytic dermatosis (Grover's disease) in a patient with gastric carcinoma. (9188891)
1997
32
Transient acantholytic dermatosis (Grover's disease): a global perspective. (8912557)
1996
33
Junctional proteins of keratinocytes in Grover's disease, Hailey-Hailey's disease and Darier's disease. (7537767)
1995
34
Desmosomal dissolution in Grover's disease, Hailey-Hailey's disease and Darier's disease. (8835169)
1995
35
Demodicidosis mimicking granulomatous rosacea and transient acantholytic dermatosis (Grover's disease). (2958377)
1987
36
Transient acantholytic dermatosis (Grover's disease). A skin disorder related to heat and sweating. (4051530)
1985
37
Immunofluorescence studies in transient acantholytic dermatosis (Grover's disease). (396810)
1979

Variations for Grover's Disease

About this section

Expression for genes affiliated with Grover's Disease

About this section
Search GEO for disease gene expression data for Grover's Disease.

Pathways for genes affiliated with Grover's Disease

About this section

GO Terms for genes affiliated with Grover's Disease

About this section

Cellular components related to Grover's Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1desmosomeGO:003005710.1DSP, JUP
2intercalated discGO:00147049.9DSP, JUP
3cell-cell junctionGO:00059119.6DSP, JUP, VCL
4fascia adherensGO:00059169.4DSP, JUP, VCL
5intermediate filamentGO:00058829.3DSP, JUP
6extracellular exosomeGO:00700628.6DSP, EGF, JUP, VCL

Biological processes related to Grover's Disease according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1adherens junction assemblyGO:003433310.0JUP, VCL
2adherens junction organizationGO:003433210.0DSP, JUP
3bundle of His cell-Purkinje myocyte adhesion involved in cell communicationGO:008607310.0DSP, JUP
4regulation of heart rate by cardiac conductionGO:00860919.9DSP, JUP
5regulation of ventricular cardiac muscle cell action potentialGO:00989119.9DSP, JUP
6single organismal cell-cell adhesionGO:00163379.8DSP, JUP
7platelet degranulationGO:00025769.7EGF, VCL
8skin developmentGO:00435889.3DSP, JUP

Molecular functions related to Grover's Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1alpha-catenin bindingGO:004529410.0JUP, VCL
2cadherin bindingGO:00452969.9JUP, VCL
3cell adhesion molecule bindingGO:00508399.9DSP, JUP
4cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communicationGO:00860839.9DSP, JUP
5structural molecule activityGO:00051988.8DSP, JUP, VCL

Sources for Grover's Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet